Joseph Beaulieu is Officer of Epizyme, Inc.. Currently has a direct ownership of 0 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Aug 12, 2022, when has been sold 52,076 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Joseph Beaulieu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Sale (or disposition) back to the issuer
-
52,076 Reduced 100.0%
0 Common Stock, par valu...
Aug 09 2022
SELL
Payment of exercise price or tax liability
$389,011 $1.39 p/Share
279,864 Reduced 84.56%
51,099 Common Stock, par valu...
Aug 09 2022
BUY
Exercise of conversion of derivative security
$417,000 $1.39 p/Share
300,000 Added 47.55%
330,963 Common Stock, par valu...
Feb 28 2022
BUY
Grant, award, or other acquisition
$2,960 $1.27 p/Share
2,331 Added 7.0%
30,963 Common Stock
Feb 07 2022
SELL
Open market or private sale
$333 $1.5 p/Share
222 Reduced 0.77%
28,632 Common Stock, par valu...
Feb 02 2022
SELL
Open market or private sale
$941 $1.37 p/Share
687 Reduced 2.33%
28,854 Common Stock, par valu...
Aug 16 2021
BUY
Grant, award, or other acquisition
-
14,833 Added 34.42%
28,264 Common Stock, par valu...
Feb 04 2021
SELL
Open market or private sale
$2,545 $11.21 p/Share
227 Reduced 1.66%
13,431 Common Stock, par valu...
Feb 01 2021
BUY
Grant, award, or other acquisition
-
7,700 Added 36.05%
13,658 Common Stock
JB

Joseph Beaulieu

Officer
Cambridge, MA

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Track Activities on EPZM